© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 02, 2021
If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.
April 01, 2021
Increasing OSA severity was associated with increasing markers of obesity.
March 05, 2021
Sleep has increased since the beginning of the pandemic in college students, while social activity has decreased.
March 02, 2021
A pooled analysis of sleep disturbance-related outcomes showed the IgE inhibitor significantly benefits a burdensome symptom of CRSwNP.
February 23, 2021
Improvements for pain did not sustain at the 12 month follow-up.
February 22, 2021
New research show the novel DNRI benefits patients both adherent and not to their OSA primary therapy.
February 05, 2021
It is the first device designed to be used during a wakeful state.
January 16, 2021
New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.
December 02, 2020
The drug is indicated in capsule form for adults and in a liquid formulation for children.
November 10, 2020
Nightware provides vibrations when it senses the user is having a nightmare.